Plutux
$3.40
+1.80%
2026-09-02 16:00:00 EDT+$0.06
Healthcare
Medical - Devices
NASDAQ
Active Trading

SS Innovations International, Inc., situated in Fort Lauderdale, Florida, focuses on the development of sophisticated robotic systems for surgical use. Their offerings ...

Price Action

$3.40
+1.80%+$0.06
High
Low
52W High-66.0%
Rel. vol
Interval
Range2.9h
VolumeSMA5SMA10
SS Innovations International, Inc. (NASDAQ: SSII) is a commercial-stage medical device and services company focused on the development and commercialization of sophisticated robotic systems for surgical applications. Founded by Dr. Sudhir Srivastava in 2016, the company aims to democratize robotic surgery by providing advanced, cost-effective solutions. The company is headquartered ...SS Innovations International, Inc. (NASDAQ: SSII) is a commercial-stage medical device and services company focused on the development and commercialization of sophisticated robotic systems for surgical applications. Founded by Dr. Sudhir Srivastava in 2016, the company aims to democratize robotic surgery by providing advanced, cost-effective solutions. The company is headquartered in Fort Lauderdale, Florida, and operates with a workforce of approximately 483 full-time employees. The company's product portfolio includes the SSI Mantra, a specialized surgical robot designed for multi-specialty procedures; SSI Mudra, a suite of surgical instruments facilitating various operations, including robotic cardiac surgery; and SSI Maya, a dedicated platform for robotic surgical interventions. Additionally, the company offers OMNI 3D HD, which delivers real-time, high-definition 3D visualization of the surgical field. From a financial perspective, SSII has a market capitalization of approximately $754 million, with a price-to-sales ratio around 15.57 and a negative price-to-earnings ratio of -70.87, reflecting its early-stage profitability. The company's gross profit margin is 48.4%, but operating margins are negative, with an EBITDA margin of -7.7%. Research and development expenses account for 7.6% of revenue, while sales and general administrative expenses are 51.7% of revenue. The company faces challenges typical of growth-stage medical device firms, including negative operating cash flow and free cash flow, but maintains a current ratio of 2.54, indicating strong short-term liquidity. Revenue per share is $0.247, and the company has a book value per share of $0.278. Key executives include CEO and Chairman Dr. Sudhir Srivastava, a globally renowned robotic cardiac surgeon. The company also has notable board members, such as Frederic Moll, a pioneer in surgical robotics. SSII is actively involved in expanding its global reach, hosting conferences like the Global SS Innovations Multi-Specialty Robotic Surgery Conference. The company is committed to innovation and accessibility, with a vision to make robotic surgery available to a wider patient population.
Founded
2016
Employees
483
CEO
Sudhir Prem Srivastava
Full Name
SS Innovations International, Inc.
Sector
Healthcare
Industry
Medical - Devices
ROE
-26.77%
Market Cap
$0.68B
Current Ratio
2.24
WACC
7.67%
ROIC
-22.24%

Contact Information

954-478-1410
1600 SE 15th Street, Fort Lauderdale, FL 33316

Related stocksMedical - Devices

Browse all US stocks

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer

© Plutux Technology Limited 2026